Simone Olgiati, PhD Merck

Dr. Simone Olgiati is head of the Innovative Sequencing & Bioinformatics Group, leading a team of scientists and bioinformaticians within the Healthcare sector of Merck. This group applies a solid expertise on high-throughput sequencing to support the manufacturing and quality control of biotechnological products by developing and validating innovative analytical methods for the detection of viral contaminants and other NGS-based applications. Dr. Olgiati holds a MSc in Biology from the University of Insubria (Italy) and a PhD in Human Genetics from the Erasmus Medical Center (the Netherlands). Before moving to Merck (Italy) in 2019, he held a bioinformatic position at Cergentis, building competencies on the genetic analysis of recombinant cell lines with the TLA technology. Moreover, he served as bioinformatician at BlueBee (currently part of Illumina), focusing on diagnostic analyses of NGS data in cloud-based environments. His professional journey allowed him to develop expertise in Big Data analytics and a broad view of NGS applications in both diagnostics and industry.